相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Translational in vitro and in vivo PKPD modelling for apramycin against Gram-negative lung pathogens to facilitate prediction of human efficacious dose in pneumonia
Vincent Aranzana-Climent et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Pharmacokinetic/pharmacodynamic models for time courses of antibiotic effects
Iris K. Minichmayr et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Clinical and pharmacokinetic/dynamic outcomes of prolonged infusions of beta-lactam antimicrobials: An overview of systematic reviews
Pierre Thabet et al.
PLOS ONE (2021)
From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotic
Sebastian G. Wicha et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Pivotal Role of Translation in Anti-Infective Development
Lena E. Friberg
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move Forward
Cornelia B. Landersdorfer et al.
FRONTIERS IN PHARMACOLOGY (2021)
Antibiotic pharmacokinetic/pharmacodynamic modelling: MIC pharmacodynamic indices and beyond
Gauri G. Rao et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting
Zahra Sadouki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Mohd H. Abdul-Aziz et al.
INTENSIVE CARE MEDICINE (2020)
What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling
Isabelle K. Delattre et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Comparison of extended versus intermittent infusion of antipseudomonal beta-lactams for the treatment of critically ill patients with respiratory infections: A systematic review and meta-analysis
Laila Aboulatta et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Prolonged versus intermittent β-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients: a systematic review with meta-analysis and trial sequential analysis of randomized trials
Yutaka Kondo et al.
JOURNAL OF INTENSIVE CARE (2020)
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Adela Benitez-Cano et al.
CRITICAL CARE (2020)
MIC-based dose adjustment: facts and fables
Johan W. Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials
Konstantinos Z. Vardakas et al.
LANCET INFECTIOUS DISEASES (2018)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia
George L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?
Federico Pea et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships
Sahand Imani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Can a pharmacokinetic/pharmacodynamic (PKPD) model be predictive across bacterial densities and strains? External evaluation of a PKPD model describing longitudinal in vitro data
Elisabet I. Nielsen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Antimicrobial Activity and Resistance: Influencing Factors
Jun Li et al.
FRONTIERS IN PHARMACOLOGY (2017)
Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae
Piergiorgio Cojutti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery
Cheng Lu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
Mohd H. Abdul-Aziz et al.
INTENSIVE CARE MEDICINE (2016)
A pharmacokinetic-pharmacodynamic (PKPD) model based on in vitro time-kill data predicts the in vivo PK/PD index of colistin
David D. Khan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model
Ami F. Mohamed et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Simulation-Based Evaluation of PK/PD Indices for Meropenem Across Patient Groups and Experimental Designs
Anders N. Kristoffersson et al.
PHARMACEUTICAL RESEARCH (2016)
Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery
Mathias Wittau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Optimization of dosing regimens and dosing in special populations
F. B. Sime et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A. Roberts et al.
LANCET INFECTIOUS DISEASES (2014)
Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population pharmacokinetics of meropenem in burn patients
Kichan Doh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Jason A. Roberts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets
Michael R. Jacobs et al.
CLINICAL INFECTIOUS DISEASES (2008)
Pharmacokinetic and pharmacodynamic properties of meropenem
David P. Nicolau
CLINICAL INFECTIOUS DISEASES (2008)
Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections
Chonghua Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Bacterial load predicts healing rate in neuropathic diabetic foot ulcers
Ling Xu et al.
DIABETES CARE (2007)
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients
Chonghua Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Pharmacokinetics and pharmacodynamics of meropenern in febrile neutropenic patients with bacteremia
RE Ariano et al.
ANNALS OF PHARMACOTHERAPY (2005)
分享论文
